Source: International Congress 2018 – Cystic fibrosis in adults: current research



Rating:

Share or cite this content

Citations should be made in the following way:
M. Contarini (Milan, Italy), A. Gramegna (Milan, Italy), S. Aliberti (Milan, Italy), G. Sotgiu (Sassari, Italy), M. Seia (Milan, Italy), L. Porcaro (Milan, Italy), A. Colombo (Milan, Italy), N. Vanoni (Milan, Italy), F. Amati (Milan, Italy), G. Pizzamiglio (Milan, Italy), M. Di Pasquale (Milan, Italy), S. Dellafiore (Milan, Italy), M. Pappalettera (Milan, Italy), C. Castellani (Verona, Italy), B. Assael (Milan, Italy), F. Blasi (Milan, Italy). Clinical characteristics and disease severity of adults with cystic fibrosis with at least one residual function mutation. 1325

Member's Comments

No comment yet.

Related content which might interest you: Long-term outcomes and clinical worsening in cystic fibrosis patients with at least one residual function mutation Source: International Congress 2018 – Cystic fibrosis in adults: current research Year: 2018 Impact of CFTR modulator use on outcomes in people with severe cystic fibrosis lung disease Source: Eur Respir Rev, 29 (155) 190112; 10.1183/16000617.0112-2019 Year: 2020 Stratifying infants with cystic fibrosis for disease severity using intestinal organoid swelling as a biomarker of CFTR function Source: Eur Respir J, 52 (3) 1702529; 10.1183/13993003.02529-2017 Year: 2018 Factors affecting progression of lung disease among patients with cystic fibrosis Source: International Congress 2019 – Physiology of cystic fibrosis Year: 2019 Hyperinflation in adult cystic fibrosis (CF) patients: Clinical and functional correlates Source: Annual Congress 2010 - Cystic fibrosis: clinical and laboratory studies Year: 2010 Lung function and disease severity in cystic fibrosis patients heterozygous for p.Arg117His Source: ERJ Open Res, 3 (1) 00056-2016; 10.1183/23120541.00056-2016 Year: 2017 Early determinants of lung disease in children with cystic fibrosis Source: Virtual Congress 2020 – New frontiers in cystic fibrosis imaging and lung physiology Year: 2020 Evaluation of disease knowledge in children with cystic fibrosis and their families Source: Annual Congress 2011 - Cystic fibrosis: clinical and laboratory studies Year: 2011 Evaluation of annual FEV1 decline and factors associated with its accelerated deterioration in a cohort of adults with cystic fibrosis Source: Annual Congress 2013 –Cystic fibrosis: clinical problems and microbiology in adults Year: 2013 How much genotype influences cystic fibrosis associated liver disease? Source: Eur Respir J 2006; 28: Suppl. 50, 717s Year: 2006 Clinical and functional profile of patients with non-cystic fibrosis bronchiectasis according to the presence of chronic bronchial infection Source: International Congress 2019 – Phenotypes and endotypes of bronchiectasis Year: 2019 Comparison of clinical features in patients with cystic fibrosis according to the age at diagnosis Source: Annual Congress 2009 - Cystic fibrosis: advances in clinical research Year: 2009 Lung clearance index and functional MRI outcomes to assess lung disease in preschool children with cystic fibrosis Source: Virtual Congress 2020 – New frontiers in cystic fibrosis imaging and lung physiology Year: 2020 Tryptic activity relates to disease severity and patient mortality in adults with cystic fibrosis Source: International Congress 2017 – Cystic fibrosis: monitoring and biomarkers Year: 2017 Clinical and functional determinants of exercise limitation in adult patients with cystic fibrosis Source: Annual Congress 2012 - Limiting factors in exercise Year: 2012 The impact of genotype on clinical course of cystic fibrosis (CF) in adult patients Source: Annual Congress 2013 –Cystic fibrosis: clinical problems and microbiology in adults Year: 2013 Risk factors for lung disease progression in children with cystic fibrosis Source: Eur Respir J, 52 (4) 1801492; 10.1183/13993003.01492-2018 Year: 2018 Risk factors for lung disease progression in children with cystic fibrosis Source: Eur Respir J, 51 (6) 1702509; 10.1183/13993003.02509-2017 Year: 2018 Bacterial burden in the lower airways predicts disease progression in idiopathic pulmonary fibrosis and is independent of radiological disease extent Source: Eur Respir J, 55 (4) 1901519; 10.1183/13993003.01519-2019 Year: 2020